Literature DB >> 19342970

Not all polyriboinosinic-polyribocytidylic acids (Poly I:C) are equivalent for inducing maturation of dendritic cells: implication for alpha-type-1 polarized DCs.

Tony Avril1, Marie de Tayrac, Claudine Leberre, Véronique Quillien.   

Abstract

This study compares the behavior of 2 commercially available polyriboinosinic-polyribocytidylic acids (poly I:C1 and poly I:C2) and the structural analog poly I:C12U in regard to dendritic cell (DC) maturation. When the Toll-like receptor 3 (TLR3) agonists are tested in combination with interferon-alpha, tumor necrosis factor-alpha, interleukin (IL)-1beta, and interferon-gamma (the so-called alpha-type-1 DC), the 3 different cocktails generate phenotypically mature DCs, but with different functional properties. Higher migratory capacity is observed with poly I:C1, the only poly I:C allowing spontaneous release of IL-12p70 by DCs. However, upon CD40 triggering, cocktails containing poly I:C2 or poly I:C12U allow a far higher production of IL-12p70 compared with those containing poly I:C1. Using a TLR signaling pathway reverse transcription profiler polymerase chain reaction to analyze changes in gene expression after treatment of DCs with the agonists alone, we show that 39% of the 84 tested genes are differentially regulated between the 3 conditions. Poly I:C12U induces far fewer regulated genes than the 2 other poly I:Cs. These different behaviors could be due to alternative ways of sensing double-stranded RNA, which do not rely solely on TLR3 but also on other types of receptors, depending on the size of poly I:Cs. As the 2 poly I:Cs tested here have very different molecular weights, this could partly explain the observed differences. In conclusion, neither the poly I:Cs nor their structural analog poly I:C12U have an equivalent behavior. This should be taken into an account not only when they are used in cocktails for DC maturation but also when analyzing signaling pathways with synthetic double-stranded RNA analogs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342970     DOI: 10.1097/CJI.0b013e31819d29bf

Source DB:  PubMed          Journal:  J Immunother        ISSN: 1524-9557            Impact factor:   4.456


  8 in total

1.  Differential responses of normal human melanocytes to intra- and extracellular dsRNA.

Authors:  Suiquan Wang; Dongyin Liu; Rong Jin; Yiping Zhu; Aie Xu
Journal:  DNA Cell Biol       Date:  2015-03-24       Impact factor: 3.311

Review 2.  Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant.

Authors:  Bo Jin; Tao Sun; Xiao-Hong Yu; Chao-Qun Liu; Ying-Xiang Yang; Ping Lu; Shan-Feng Fu; Hui-Bin Qiu; Anthony E T Yeo
Journal:  J Biomed Biotechnol       Date:  2010-07-05

3.  Activation of Toll-Like Receptor 3 Induces Interleukin-1 Receptor Antagonist Expression by Activating the Interferon Regulatory Factor 3.

Authors:  Yang Liu; Chun-Fen Mo; Xing-Yan Luo; Hua Li; Hui-Jie Guo; Hai Sun; Song Hu; Li-Mei Li; Yan-Tang Wang; Shu-Xia Yang; Shan Chang; Qiang Zou
Journal:  J Innate Immun       Date:  2019-12-20       Impact factor: 7.349

Review 4.  RNA mediated Toll-like receptor stimulation in health and disease.

Authors:  Alexander Dalpke; Mark Helm
Journal:  RNA Biol       Date:  2012-05-23       Impact factor: 4.652

5.  Intranasal administration of dsRNA analog poly(I:C) induces interferon-α receptor-dependent accumulation of antigen experienced T cells in the airways.

Authors:  Beth McNally; Meredith Willette; Fang Ye; Santiago Partida-Sanchez; Emilio Flaño
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

6.  PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In Vivo.

Authors:  Meropi Aravantinou; Ines Frank; Magnus Hallor; Rachel Singer; Hugo Tharinger; Jessica Kenney; Agegnehu Gettie; Brooke Grasperge; James Blanchard; Andres Salazar; Michael Piatak; Jeffrey D Lifson; Melissa Robbiani; Nina Derby
Journal:  PLoS One       Date:  2016-09-07       Impact factor: 3.240

7.  Discordant biological and toxicological species responses to TLR3 activation.

Authors:  William M Mitchell; Christopher F Nicodemus; William A Carter; Joseph C Horvath; David R Strayer
Journal:  Am J Pathol       Date:  2014-01-30       Impact factor: 4.307

Review 8.  Exploiting poly(I:C) to induce cancer cell apoptosis.

Authors:  Francesca Bianchi; Samantha Pretto; Elda Tagliabue; Andrea Balsari; Lucia Sfondrini
Journal:  Cancer Biol Ther       Date:  2017-09-07       Impact factor: 4.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.